| Study name |
Multicenter, double‐blind, placebo‐controlled, randomized, in two parallel groups study of the efficacy of Cortexin®, 10 mg, manufactured by GEROPHARM LLC, Russia, in patients in the acute period of ischemic stroke |
| Methods |
Multicentre, double‐blind, placebo‐controlled, randomised study, in 2 parallel groups |
| Participants |
320 |
| Interventions |
Cortexin®, 10 mg, manufactured by GEROPHARM LLC, lyophilisate for solution for intramuscular injection, 10 mg. No further details provided |
| Outcomes |
No details provided |
| Starting date |
29 August 2019 |
| Contact information |
Limited Liability Company "GEROPHARM", 000000, St. Petersburg, 191119, St. Petersburg, st. Zvenigorodskaya, 9, Russia |
| Notes |
End date ‐ 31 December 2027 |
